As with alllofty visionssuchas this, itwill take immense commitment from quality entrepreneurs to accomplish. Michael S. Weiss and Dr. Lindsay Rosenwald created OpusPoint Partners in 2009 with the idea of combining their 40 years of experience and business acumen working toward revolutionizing the fields of healthcare, life sciences and biotechnology investing. Both these men are well equipped to do this job and have already founded a number of biotech companies over the years.

With so much at stake, OpusPoint Partners along with Dr. Lindsay Rosenwald, is working toward making those leaps to advance and even transform the world of life sciences and biotechnology investing. Rosenwald, along with his team at OpusPoint, believe in a future where mankind significantly improves the quality of healthcare, as well as healthcare investing.

Advancements in the Future of Healthcare

Recently, Dr. Lindsay A. Rosenwaldfounded Cougar Biotechnology Inc. This Los Angeles-based company focuses on the field of oncology. Their oncology portfolio includes some very promising experimental drugs, which are proving to be effective in treatingnumerousforms of cancer.

One in particular has caused some excitement and drawn the interests of researchers and investors. It is a new drug that has been proven to work well at treating late-stage prostate cancer. In July of 2009, Dr. Lindsay Rosenwaldwas able to negotiate a deal with Johnson & Johnson for Cougar Biotech Labs at a price of approximately one billion dollars.

Realizing the Objectives
Lindsay Rosenwald and OpusPoint Partners believe they can continue to move forward with projects like these that alter healthcare significantly and produce results for the greater good of mankind. They achieve these goals with integrity, building solid relationships in both the world of investing and biotechnology.

Establishing robust relationships withother industry leaders who share similar values is a hallmark of the business strategy of both Dr. Lindsay Rosenwald and OpusPoint Partners. They believe in reaching goals and objectives through honesty, integrity and hard work. Their success has proven that you can obtain these objectives without the sacrifice ofprinciples and standards. Honest investing with full and open disclosure is more than just good business for OpusPoint Partners. This is the ideology they live by.

Creating New Partnerships for a Better Tomorrow
Dr. Lindsay Rosenwald and OpusPoint Partners currently work with a wide range of businesses and organizations to create a team approach for thesupport of emerging new businesses. They are making great strides toward building a powerful network of like-minded individuals who all possess a genuine commitment to discover and invest in innovative technologies in the fields of life sciences and healthcare.

With pioneers such as these in the areas of research and investment, you can be sure that thefuture of healthcare and life sciences will continue to flourish. These days, the medical field is well-aware of its need for diseases of all types to be diagnosed and treated by more effective methods. At OpusPoint Partners, Dr. Lindsay Rosenwald, his business partners and colleagues, know that the dream can become a reality with hard work and dedication.

The dream of a better tomorrow continues to be the fuel that fires this vision of a much stronger quality of life for us all. And thisunique vision of making a true difference in the world has become a driving force for Dr. Lindsay Rosenwald and OpusPoint Partners. History shows that dreams like this always take time, money and hard work, plus dedication from those involved.

Raising the Bar for Investors
Over the course of this journey, Dr. Lindsay Rosenwald and OpusPoint Partners must oftenprovide advisory services to start-up businesses. At times they also must invest in publicly-traded companies in order to move the vision forward.

One of their key objectives is to raise the bar for all investors. Whether working in the advisory capacity with emerging biotechnical research facilities or actually investing, OpusPoint followsa strong moral compass.With sound business principleslike these, the risks can be significantly minimizedand the returns for investors maximized. This uniqueformula has proven successful beyond anyone’s wildest dreams.

Utilizing Ethical Business Practices
The philosophy behind OpusPoint Partners is to build a positive and effective life science and healthcare network that plays fair and won’t take short cuts to reach its goals. Dr. Rosenwaldknows from experience, that today’s world often provides many opportunities for business leaders to use less than ethical tactics to try and manipulate outcomes of clinical trials with an eye toward greaterquarterly earnings. Does the end justify the means?

At OpusPoint Partners, the answer is a resounding no! This unique enterprise continually reinforces its commitment to its employees and investors to conduct business with higher standards than many of days gone by. In the investigation and manufacture of experimental drugs, they are resolute about this commitment to honest, above-board business dealings.

A Long and Fruitful Career
The future of OpusPoint Partners remains highly promising with Michael S. Weiss and Dr. Lindsay Rosenwald as its founders. They are utilizing their expertise in the fields of medicine and investments to effect some very real changes in the way diseases are diagnosed. They believe that the treatment of patients can be transformed.

Dr. Rosenwald, a well-respected Wall Street biotechnology entrepreneur, has worked for the past 17 years utilizing strong business ethics in the founding and re-capitalization of dozens of private and public biotechnology and life-sciences companies. He earned his M.D. from the Temple University School of Medicine and his B.S. in Finance from Pennsylvania State University.

Throughout an impressive twenty-year career, Dr. Lindsay Rosenwald has established over fifty companies. He also managed the Aries Funds from 1994 through 2007 with peak assets under his management in 2000 of over $1BB dedicated to healthcare investments. From 2002 to 2006, hemanaged the Orion Fund, which was a committed capital fund dedicated to private investments in biotechnology, in particular PIPEs.

Dr. Lindsay Rosenwald is currently a member of the Board of Directors at the Republican Jewish Coalition. He is one of the most broadly-informed and well-connected individuals in the biotechnology finance sector. The future ofOpusPoint Partners indeed looks promising with Dr. Rosenwald at its helm.

At www.muckety.com, Dr. Lindsay Rosenwald’s relationship to the Republican Jewish Coalition is visually illustrated in a diagram-like map.

www.youtube.com/watch?v=s485sqUgSzc

Dr. Lindsay Rosenwald has a profile on Wellness.com that displays his education, current practice, and services offered.  He is a graduate of Temple University Medical School, and he presently works as a general practitioner in New York City.  As a general practitioner, Dr. Lindsay Rosenwald provides an array of services which include bone density testing, immunizations, physical examinations, and stress reduction plans.

The NyICECATS have recognized Dr. Lindsay Rosenwald on multiple occasions as an exceptional member of the organization’s adult team.  The NyICECATS is a Jewish Orthodox youth hockey organization that has branched out to adults.  At both the third and fourth annual Captain’s Dinner, held on March 12^th at Le Marais in New York City, Dr. Lindsay Rosenwald was honored and presented with gifts by Neil Herskowitz, who is the Director of Manhattan Pharmaceutical, Inc.  The gifts of team included a Bauers 190.  As the night went on, Dr. Lindsay Rosenwald made an announcement that he was committed to playing hockey at the Piers for 25 more years.  The dinner concluded with the “Golden Balls” award ceremony.

A search for Dr. Lindsay Rosenwald in the Huffington Post’s FundRace of 2008 displays his donation to the McCain Victory Committee of $61,800.

Dr. Lindsay Rosenwald can also be known to start companies which were the inventories to the new drugs that help the human life a lot by curing the diseases that affect human body by making them weak. Cougar Biotechnology and Polarx Biopharmaceuticals are the two most popularly known companies under the foundation of Rosenwald. These two companies invented two new drugs in addition to the older ones. Though these drugs are being developed by the companies under Rosenwald’s guidance they are being allowed to enter the market after few medical tests. Drugs are the one which are known scientifically as life Savers.

All the inventions and developments of the drugs are done by highly qualified people related to various fields of Biotechnology under scientific research. It can be said that the team is grouped in accordance to the experts who are highly skilled with the practical and theoretical knowledge. The formulation of the drug and its manufacturing are done in a process like technology transfer, pharmacology and toxicology aspects of the drug, clinical development, regulatory, marketing, etc. The sacrifices of these team members are valued with the success selling of their products in the market.

It is Dr. Lindsay Rosenwald was a person by whom many new young Biotechnologists where inspired and laid new ways to further success. Drugs under Rosenwald’s foundation helped to cure more deadly diseases which can be thought as the one having no treatment. Rosenwald was the one with two invaluable features which were both as per financial and physician analysts.

Dr. Lindsay Rosenwald reputed himself as a corporate finance managing director for D.H. Blair & Company, in the year of 1988. This was a privately owned investment based business. There, he was the leader of a team of three physician-financiers that sought through the medical community for any new and profitable break-through that could make use of private investment. They located various schools of medicine, universities, hospitals, drug companies, study groups, and scientific firms. He has worked within the biotechnology and bioresearch disciplines. Dr. Rosenwald serves on the Columbia-Presbyterian Health Sciences Advisory Counsel and in the 2002 article edition of Genetic Engineering News he was ranked number one in the list of 100 Molecular Millionaires with a worth of $617,721,671. Dr. Lindsay Rosenwald operated on the Keryx Biopharmaceutical, Inc board of directors from 2002 to 2006. He quit in order to contribute additional time performing in the biotechnology market. Cougar Biotechnology, purchased by Johnson & Johnson in 2009, is another business that was first founded by Dr. Rosenwald and was originated completely on abiraterone acetate. Abiraterone Acetate, even though it had not yet attained phase III in clinical testing trials, was showing so much potential in the therapy and management for prostate cancer that Johnson & Johnson offered a short-term unification bid and procurement  for the Cougar Biotechnology corporation for $1 billion. Dr. Lindsay Rosenwald, apart from the scores of ventures which have imparted financing and resources to portfolio companies, has also began the Rosenwald Foundation. This is a nonprofit outfit that has been triumphant in offering millions of dollars in aid of many medical and scientific instruction institutions.

Rosenwald graduated from Abington High School in Pennsylvania in 1973. He went on to attend Penn State University and graduated as a part of the Betta Gamma Sigma business school honor society in 1977, having received his degree in finance. He then attended Temple University’s School of Medicine where he receive his doctorate in 1983. He began work in Abington Medical Hospital but started a private practice soon thereafter. Taking his abilities from his private practice to Wall Street, Lindsay Rosenwald began using both finance specialization and his unique insights into the medical industry to work in an advisory capacity. This would become the foundation of the work for which he is best known.

He has helped these companies (once they have been located ans supported) by assisting them in making effective corporate plans, business strategies, and provide basic business and strategic support. These landmark companies have all been a significant part of Lindsay Rosenwald‘s contribution to the industry, and are behind his widely acknowledged reputation as one of the forerunners in the biomedical industry, both as a contributor, entrepreneur, and developer. Over the last two decades, repeated success has solidified this reputation. The companies that he has established, developed, or invested in, have had an immense impact on the industry as a whole. The contributions have not only been financially successfully, but revolutionary in the industry, making significant progress in treatment for prostate cancer, leukemia, dense tumors, and more. Lindsay Rosenwald and his contributions do not seem to be waning. Rather, over the last three years, we have seen a significant increase in the number of investments made. The innumerable accomplishments that Lindsay Rosenwald’s work has led to in the biotechnology and bioresearch fields include a few notable highlights. From a financial perspective, we have seen major success, with notable examples like Sanctura. The impact on the medical field itself, with astonishing progress in areas like leukemia, tumor, and cancer treatment, are just a few of the more significant items of note. The acquisitions from outside companies may be one of the greatest signals of how successful Lindsay Rosenwald has been. Groups like Johnson & Johnson, Albany Molecular, and Myriad Pharmaceuticals, have acquired portfolio and the total cost of acquisitions have exceed $1 billion. All of this success may root back to the double disciplines that Lindsay Rosenwald chose to pursue.

Having experience in both the financial sector and in medicine and biotechnology, Lindsay Rosenwald has been able to offer insights that are matched by few others in the history of modern healthcare. He is not only able to seek out those companies which show great potential, he is also able to accurately foresee the challenges they may face, and prepare them with resources and strategies to cope with those challenges successfully. Lindsay Rosenwald has selflessly established the Rosenwald foundation. This nonprofit organization has contributed millions of dollars to medical education institutions and other scientific communities, laying the groundwork for the revolutionary advances of the future. Lindsay Rosenwald has many accomplishments that he can successfully claim. He is the founder of a company which has led to some of the greatest pharmaceutical and biotechnology advancements over the last two decades. He is a successful entrepreneur and forerunner in the finance industry. His dual disciplines in finance and medicine have allowed him to have an impact that few others have had in the history of biomedicine, and in recent years, Lindsay Rosenwald is widely seen as the greatest contributor to the industry.

www.youtube.com/watch?v=rZI3tAvqa1o

Should there be doubt of these unique traits, simply observe how the Rosenwalds parent.  Not content to simply support charities in an offhand or sidelined way, they have made it a part of their home life.  They hold various fund raisers and events centered around several organizations focusing on children with the aim of setting an example and providing a path for their children to follow.  In taking a look at the big-picture of various platforms they support, it becomes clear that the Rosenwalds are primarily and daily concerned with bettering the future of mankind.  Their efforts focus on programs and institutions concerned with societal improvement with a strong focus on education.  It’s increasingly uncommon to find individuals who not only simply donate to groups around the world, but also foster direct relationships with many individuals in need.

One does not need to search far to hear a story or two about Dr. Lindsay Rosenwald’s generosity.  An example would be an artist who, through sponsorship by Lindsay Rosenwald, has found their paintings to be hanging at the Institute’s headquarters.  Although spectacular in their own right, Lindsay Rosenwald bought the paintings solely to assist the painter.  The Rosenwalds were also honored at one of Sh’or Yoshuv’s previous events.  Reluctantly accepting the award, Lindsay Rosenwald stated, “I don’t like the lime light, but you know I will do what it takes to help you.”

The most telling account centers around a time when the Institute was in a very dire budget crisis.  Dr. Lindsay Rosenwald held a meeting in his home to resolve this issue.  Holding his silence through the entire meeting, Lindsay Rosenwald then approached the Rabbi and quietly assured him that he would front the shortfall in while.  He was sensitive to the fact that the room was full of people, and required no personal lauding for his generosity.

The Institute has proudly dedicated its campus atrium to Mr. David R. Rosenwald, Esquire, Lindsay Rosenwald’s late father.  As personal friends to Sh’or Yoshuv Institute, the Rosenwalds participate in the High Holy Days and a multitude of other spiritual services.  With a lasting and true commitment to their background, the Rosenwalds are irrevocably a part of the solid base that keep the Institute going as a unique hub of Jewish Education.

On the day of the interview, I was escorted into Lindsay Rosenwald’s office where I  sat office for about six hours:  talking occasionally, watching him take multiple calls at once, handle an endless round of visitors and calmly direct trades as he observed the market from any one of the four terminals showing market activity.   At the end of the day, he told me I was hired, and that I should come back in the morning to discuss details.

That evening, I remember calling my brother, Tom, and telling him about my day.   He shouted through the phone:  “You met with who?!    Do you have any idea who Lindsay Rosenwald is?!!!”

To say it was a meeting that changed my life forever, would at best be an understatement.

Lindsay gave me an opportunity that I would bet no one or at best very few would have given me.     I was media-regular, offering nutritional advice with no understanding whatsoever of the public markets.   Yet, still, Lindsay Rosenwald took a chance and introduced me  to the world of venture capital, merchant banking, public companies and financing.    It was a fascinating, hockey-stick learning experience that was intense, exciting, and life-changing.

Today, I am eternally grateful to Lindsay.   I consider him both a mentor and friend.  In a most informal way, he taught me valuable lessons that I cite regularly;

Pick a direction and stay focused.

Pioneers get the arrows, settlers get the land.

It is better to own 10% of the goldmine, than 100% of the shaft.

Don’t worry about idle gossip if its about you…it is really idol worship.

Lindsay is smart.    He works hard.   He is relentless.    I admire those traits.     But mostly, I will never forget that in so many ways the least likely candidate  for the job—he sees potential in things that most people simply miss.    He nurtures that potential.    He provides the environment to develop technologies and for people to think, grow, reach, expand, create and try.
Whether he is acknowledged and thanked for it, Lindsay single-handedly launched more successful careers than I can count.    We all had talent.    But whether we choose to admit it or not, we often come to our own greatness by the unselfish, helping hands of others.     To so many, Lindsay has been that helping hand:   to me starting an investor relations firm, to those who launched funds, and to the countless public companies that he created which in turn offered both jobs and opportunities.

Because of this, Lindsay Rosenwald was recognized in 2007 as JHP’s “Mentor of the Year.”  At an event held in June of that year, Dr. Lindsay Rosenwald accepted this honor along with other honorees as Andrew Schwartz, a graduate alumni honoree, as well as Mr. Jonathan Golub, a Strategist with Bear Stearns and prolific longtime supporter of JHP.

Since its founding in 1993, Jewish Heritage Programs has assisted over 65,000 Jewish college students across 10 campuses.  Members students organize their own events and meetings, developing long-standing ties to other students, professionals, and the Jewish community at large.  Involvement from individuals such as Dr. Lindsay Rosenwald has proven invaluable to JHP’s efforts to connect a myriad of Jewish students to their heritage and community.